换一批Comparative effectiveness and cost-effectiveness of natalizumab and fingolimod in rapidly evolving severe relapsing-remitting multiple sclerosis in the United Kingdom.
第一作者：
T,Spelman
第一单位：
MSBase Foundation, Melbourne, VIC, Australia.;Department of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden.
作者：
T,Spelman [1]
;
W L,Herring [2]
;
C,Acosta [3]
;
R,Hyde [4]
;
V G,Jokubaitis [5]
;
E,Pucci [6]
;
A,Lugaresi [7]
;
G,Laureys [8]
;
E K,Havrdova [9]
;
D,Horakova [9]
;
G,Izquierdo [10]
;
S,Eichau [10]
;
S,Ozakbas [11]
;
R,Alroughani [12]
;
T,Kalincik [13]
;
P,Duquette [14]
;
M,Girard [14]
;
T,Petersen [15]
;
F,Patti [16]
;
T,Csepany [17]
;
F,Granella [18]
;
F,Grand'Maison [19]
;
D,Ferraro [20]
;
R,Karabudak [21]
;
M,Jose Sa [22]
;
M,Trojano [23]
;
V,van Pesch [24]
;
B,Van Wijmeersch [25]
;
E,Cartechini [26]
;
P,McCombe [27]
;
O,Gerlach [28]
;
D,Spitaleri [29]
;
C,Rozsa [30]
;
S,Hodgkinson [31]
;
R,Bergamaschi [32]
;
R,Gouider [33]
;
A,Soysal [34]
;
Castillo-Triviño [35]
;
J,Prevost [36]
;
J,Garber [37]
;
K,de Gans [38]
;
R,Ampapa [39]
;
M,Simo [40]
;
J L,Sanchez-Menoyo [41]
;
G,Iuliano [42]
;
A,Sas [43]
;
A,van der Walt [44]
;
N,John [45]
;
O,Gray [46]
;
S,Hughes [47]
;
G,De Luca [48]
;
M,Onofrj [49]
;
K,Buzzard [50]
;
O,Skibina [51]
;
M,Terzi [52]
;
M,Slee [53]
;
C,Solaro [54]
;
Oreja-Guevara [55]
;
C,Ramo-Tello [56]
;
Y,Fragoso [57]
;
V,Shaygannejad [58]
;
F,Moore [59]
;
C,Rajda [60]
;
E,Aguera Morales [61]
;
H,Butzkueven [5]
作者单位：
MSBase Foundation, Melbourne, VIC, Australia.;Department of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden.
[1]
Health Economics, RTI Health Solutions, NC, USA.;Department of Neurobiology, Care Sciences and Society, Karolinska Institute, Stockholm, Sweden.
[2]
Value and Access, Biogen, Baar, Switzerland.
[3]
Medical, Biogen, Baar, Switzerland.
[4]
Department of Neuroscience, Central Clinical School, Monash University, Melbourne, Australia.
[5]
Neurology Unit, AST-Fermo, Fermo, Italy.
[6]
Dipartamento di Scienze Biomediche e Neuromotorie, Università di Bologna, Bologna, Italy.;IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy.
[7]
Department of Neurology, University Hospital Ghent, Ghent, Belgium.
[8]
Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.
[9]
Department of Neurology, Hospital Universitario Virgen Macarena, Seville, Spain.
[10]
Izmir University of Economics, Medical Point Hospital, Izmir, Turkey.
[11]
Division of Neurology, Department of Medicine, Amiri Hospital, Sharq, Kuwait.
[12]
Neuroimmunology Centre, Department of Neurology, Royal Melbourne Hospital, Melbourne, Australia.;CORe, Department of Medicine, University of Melbourne, Melbourne, Australia.
[13]
CHUM and Universite de Montreal, Montreal, Canada.
[14]
Aarhus University Hospital, Arhus C, Denmark.
[15]
Department of Medical and Surgical Sciences and Advanced Technologies, GF Ingrassia, Catania, Italy.;UOS Sclerosi Multipla, AOU Policlinico "G Rodloico-San Marco", University of Catania, Italy.
[16]
Department of Neurology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
[17]
Department of Medicine and Surgery, University of Parma, Parma, Italy.;Department of General Medicine, Parma University Hospital, Parma, Italy.
[18]
Neuro Rive-Sud, Quebec, Canada.
[19]
Department of Neuroscience, Azienda Ospedaliera Universitaria, Modena, Italy.
[20]
Hacettepe University, Ankara, Turkey.
[21]
Department of Neurology, Centro Hospitalar Universitario de Sao Joao, Porto, Portugal.;Faculty of Health Sciences, University Fernando Pessoa, Porto, Portugal.
[22]
School of Medicine, University of Bari, Bari, Italy.
[23]
Cliniques Universitaires Saint-Luc, Brussels, Belgium.;Université Catholique de Louvain, Belgium.
[24]
University MS Centre, Hasselt-Pelt and Noorderhart Rehabilitation & MS, Pelt and Hasselt University, Hasselt, Belgium.
[25]
Neurology unit, AST Macerata, Macerata, Italy.
[26]
University of Queensland, Brisbane, Australia.;Royal Brisbane and Women's Hospital, Herston, Australia.
[27]
Academic MS Center Zuyd, Department of Neurology, Zuyderland Medical Center, Sittard-Geleen, The Netherlands.;School for Mental Health and Neuroscience, Maastricht University, Maastricht, The Netherlands.
[28]
Azienda Ospedaliera di Rilievo Nazionale San Giuseppe Moscati Avellino, Avellino, Italy.
[29]
Jahn Ferenc Teaching Hospital, Budapest, Hungary.
[30]
Immune Tolerance Laboratory Ingham Institute and Department of Medicine, UNSW, Sydney, Australia.
[31]
IRCCS Mondino Foundation, Pavia, Italy.
[32]
Department of Neurology, LR18SP03 and Clinical Investigation Center Neurosciences and Mental Health, Razi University Hospital -, Mannouba, Tunis, Tunisia.;Faculty of Medicine of Tunis, University of Tunis El Manar, Tunis, Tunisia.
[33]
Bakirkoy Education and Research Hospital for Psychiatric and Neurological Diseases, Istanbul, Turkey.
[34]
Hospital Universitario Donostia and IIS Biodonostia, San Sebastián, Spain.
[35]
CSSS Saint-Jérôme, Saint-Jerome, Canada.
[36]
Westmead Hospital, Sydney, Australia.
[37]
Groene Hart Ziekenhuis, Gouda, Netherlands.
[38]
Nemocnice Jihlava, Jihlava, Czech Republic.
[39]
Department of Neurology, Semmelweis University Budapest, Budapest, Hungary.
[40]
Department of Neurology, Galdakao-Usansolo University Hospital, Osakidetza Basque Health Service, Galdakao, Spain.;Biocruces-Bizkaia Health Research Institute, Spain.
[41]
Ospedali Riuniti di Salerno, Salerno, Italy.
[42]
Department of Neurology and Stroke, BAZ County Hospital, Miskolc, Hungary.
[43]
Department of Neuroscience, Central Clinical School, Monash University, Melbourne, Australia.;Department of Neurology, The Alfred Hospital, Melbourne, Australia.
[44]
Monash University, Clayton, Australia.;Department of Neurology, Monash Health, Clayton, Australia.
[45]
South Eastern HSC Trust, Belfast, United Kingdom.
[46]
Royal Victoria Hospital, Belfast, United Kingdom.
[47]
MS Centre, Neurology Unit, "SS. Annunziata" University Hospital, University "G. d'Annunzio", Chieti, Italy.
[48]
Department of Neuroscience, Imaging, and Clinical Sciences, University G. d'Annunzio, Chieti, Italy.
[49]
Department of Neurosciences, Box Hill Hospital, Melbourne, Australia.;Monash University, Melbourne, Australia.;MS Centre, Royal Melbourne Hospital, Melbourne, Australia.
[50]
Department of Neurology, The Alfred Hospital, Melbourne, Australia.;Monash University, Melbourne, Australia.;Department of Neurology, Box Hill Hospital, Melbourne, Australia.
[51]
Medical Faculty, 19 Mayis University, Samsun, Turkey.
[52]
Flinders University, Adelaide, Australia.
[53]
Department of Neurology, ASL3 Genovese, Genova, Italy.;Department of Rehabilitation, ML Novarese Hospital Moncrivello.
[54]
Department of Neurology, Hospital Clinico San Carlos, Madrid, Spain.
[55]
Department of Neuroscience, Hospital Germans Trias i Pujol, Badalona, Spain.
[56]
Universidade Metropolitana de Santos, Santos, Brazil.
[57]
Isfahan University of Medical Sciences, Isfahan, Iran.
[58]
Department of Neurology, McGill University, Montreal, Canada.
[59]
Department of Neurology, University of Szeged, Szeged, Hungary.
[60]
Department of Medicine and Surgery, University of Cordoba, Cordoba, Spain.;Maimonides Biomedical Research Institute of Cordoba (IMIBIC).
[61]
医学主题词
人类(Humans);多发性硬化, 复发缓解性(Multiple Sclerosis, Relapsing-Remitting);免疫抑制剂(Immunosuppressive Agents);多发性硬化(Multiple Sclerosis);费用效益分析(Cost-Benefit Analysis);公费医疗(State Medicine)
DOI
10.1080/13696998.2023.2293379
PMID
38085684
发布时间
2023-12-27
- 浏览0
Journal of medical economics
Journal of medical economics
109-125页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
